Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A1 | Q13285 | 1/20 | 0.60 |
| ▸ | LTA4H | P09960 | 4/20 | 0.53 |
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | PLA2G4B | P0C869 | 3/20 | 0.51 |
| ▸ | RARB | P10826 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL338316 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL1609987 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL1611001 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL309133 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL987954 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL77477 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL9121701 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL263776 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL988767 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL1610778 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1454903-B9 | Thiadiazoline derivatives for treating cancer | KYOWA HAKKO KIRIN CO LTD (JP) | 2011-10-05 | — | — | EP | claimed |
| EP-1454903-B1 | Thiadiazoline derivatives for treating cancer | KYOWA HAKKO KIRIN CO LTD (JP) | 2010-09-08 | — | — | EP | claimed |
| US-20080207706-A1 | THIADIAZOLINE DERIVATIVE | KYOWA HAKKO KOGYO CO., LTD (JP) | 2008-08-28 | — | — | US | claimed |
| US-20060074113-A1 | Thiadiazoline derivative | KYOWA KIRIN CO., LTD. (JP) | 2006-04-06 | — | — | US | claimed |
| EP-1454903-A1 | THIADIAZOLINE DERIVATIVE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2004-09-08 | — | — | EP | claimed |
| EP-0267585-B1 | FLUOROALKANE DERIVATIVE, ITS COMPOSITION AND LIQUID CRYSTAL DEVICE USING SAME | CANON KABUSHIKI KAISHA (JP) | 1993-09-15 | — | — | EP | claimed |
| US-4604471-A | PLASTIC STABILIZERS | BASF AKTIENGESELLSCHAFT (DE) | 1986-08-05 | — | — | US | claimed |
| CN-111315828-B | Composition, cured product, optical filter, and method for producing cured product | 株式会社艾迪科 | 2023-09-29 | — | — | CN | disclosed |
| CN-112154167-B | Composition, cured product, optical filter, and method for producing cured product | 株式会社艾迪科 | 2023-08-22 | — | — | CN | disclosed |
| CN-110494501-B | Phthalocyanine compound and use thereof | 山本化成株式会社 | 2022-04-19 | — | — | CN | disclosed |
| WO-2022059590-A1 | LIGHT- OR HEAT-RESPONSIVE CLEAVAGE MOLECULAR LAYER | 国立研究開発法人産業技術総合研究所 | 2022-03-24 | — | — | WO | disclosed |
| CN-107151264-B | Novel glycopeptide antibiotic derivative, pharmaceutical composition, preparation method and application thereof | 浙江医药股份有限公司新昌制药厂 | 2021-11-23 | — | — | CN | disclosed |
| US-11015061-B2 | Phthalocyanine-based compound and uses of same | YAMAMOTO CHEMICALS, INC. (JP) | 2021-05-25 | — | — | US | disclosed |
| US-4555355-A | Composition for liquid crystal color display | MITSUI TOATSU CHEMICALS, INC. (JP) | 1985-11-26 | — | — | US | disclosed |
| EP-0143397-A2 | Furan-3-hydroxamates and their use | BASF Aktiengesellschaft (DE) | 1985-06-05 | — | — | EP | disclosed |
| EP-0140133-A2 | Liquid crystal phase-forming polymers | BASF Aktiengesellschaft (DE) | 1985-05-08 | — | — | EP | disclosed |
| EP-0060895-B1 | COMPOSITION FOR LIQUID CRYSTAL COLOR DISPLAY | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1985-05-02 | — | — | EP | disclosed |
| EP-0120463-A2 | Anthraquinone dyes and liquid crystal compositions including the same | HITACHI, LTD. (JP) | 1984-10-03 | — | — | EP | disclosed |
| US-4459218-A | Composition for liquid crystal color display | MITSUI TOATSU CHEMICALS, INC. (JP) | 1984-07-10 | — | — | US | disclosed |
| EP-0060895-A1 | COMPOSITION FOR LIQUID CRYSTAL COLOR DISPLAY | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1982-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060074113-A1 | Thiadiazoline derivative | BRWD1, RB1, ARG2 | NR5A1 1667/4885LTA4H 2357/4885TP53 18/4885 |
| US-20080207706-A1 | THIADIAZOLINE DERIVATIVE | BRWD1, RB1, ARG2 | NR5A1 1667/4885LTA4H 2357/4885TP53 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.